A Lancet Oncology study estimates 2.3 million new cancers in 2024—about 12% of the global total—were attributable to infections, led by H. pylori and HPV and concentrated in low‑ and middle‑income countries (Eastern Asia accounted for ~42% of the burden). The finding highlights that vaccination, treatment, and infection control are concrete levers to prevent millions of cancer cases.
— Reframes a sizable share of the global cancer burden as preventable through public‑health measures (vaccination, antimicrobial treatment, screening), raising questions about funding, global vaccine access, and health‑system priorities.
BeauHD
2026.10.03
100% relevant
Lancet Oncology dataset reporting 2.3 million infection‑attributable cancers in 2024 with pathogen breakdowns (H. pylori 760k; HPV 750k; HBV 360k; EBV 260k; HCV 160k) and geographic concentration in Eastern Asia and other lower‑income regions.
← Back to all ideas